Sarepta Therapeutics, Inc. (SRPT)

NASDAQ: SRPT · IEX Real-Time Price · USD

117.12

+0.16 (0.14%)

At close: Apr 23, 2024, 4:00 PM

116.99

-0.13 (-0.11%)

After-hours: Apr 23, 2024, 7:11 PM EDT

Sarepta Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013 - 1996
Cash & Equivalents	428.43	966.78	2,116	1,503	835.08	370.83	599.69	122.42	81.09	74.33	Upgrade
Short-Term Investments	1,248	1,023	0	435.92	289.67	803.08	479.37	206.12	122.88	136.79	Upgrade
Cash & Cash Equivalents	1,676	1,989	2,116	1,939	1,125	1,174	1,079	328.54	203.97	211.13	Upgrade
Cash Growth	-15.74%	-5.98%	9.15%	72.36%	-4.19%	8.79%	228.44%	61.07%	-3.39%	-20.29%	Upgrade
Receivables	400.33	214.63	152.99	101.34	90.88	49.04	29.47	5.23	3.98	2.42	Upgrade
Inventory	514.23	366.51	186.21	231.96	171.38	125.45	83.61	12.81	0	0	Upgrade
Other Current Assets	-11.47	-12.65	149.03	213.32	81.91	77.78	36.51	26.9	16.6	34.25	Upgrade
Total Current Assets	2,579	2,558	2,604	2,485	1,469	1,426	1,229	373.48	224.54	247.8	Upgrade
Property, Plant & Equipment	357.11	244.99	236.69	282.19	167.55	97.02	43.16	37.8	37.34	38.5	Upgrade
Long-Term Investments	0	0	0	0	0	0	21.81	4.75	0	0	Upgrade
Goodwill and Intangibles	0	0	14.24	13.63	12.5	11.57	14.36	8.08	6.64	5.89	Upgrade
Other Long-Term Assets	328.14	325.51	292.95	203.7	173.86	107.29	0	0	5.25	2.85	Upgrade
Total Long-Term Assets	685.25	570.51	543.88	499.52	353.91	215.89	79.32	50.63	49.24	47.24	Upgrade
Total Assets	3,265	3,128	3,148	2,985	1,823	1,642	1,308	424.1	273.78	295.03	Upgrade
Accounts Payable	164.92	95.88	76.74	111.09	68.09	33.83	8.47	29.69	20.23	12.41	Upgrade
Deferred Revenue	487.42	574.24	663.49	752.73	3.3	0	3.32	3.3	3.3	3.32	Upgrade
Current Debt	123.33	15.49	0	0	0	0	6.18	10.11	8.43	2.59	Upgrade
Other Current Liabilities	-122	-66	-287.5	-447.8	193.37	139.86	70.37	32.32	30.33	18.55	Upgrade
Total Current Liabilities	653.66	619.6	452.73	416.03	264.77	173.69	88.33	75.42	62.29	36.87	Upgrade
Long-Term Debt	1,273	1,602	1,138	1,073	729.62	420.55	424.88	6.04	14.97	3.74	Upgrade
Other Long-Term Liabilities	478.1	521.94	628.84	734.07	10.25	15.56	5.54	5.95	6.17	6.78	Upgrade
Total Long-Term Liabilities	1,752	2,124	1,767	1,807	739.87	436.11	430.42	11.99	21.14	10.51	Upgrade
Total Liabilities	2,405	2,743	2,220	2,223	1,005	609.8	518.75	87.41	83.44	47.38	Upgrade
Total Debt	1,397	1,617	1,138	1,073	729.62	420.55	431.05	16.15	23.4	6.33	Upgrade
Debt Growth	-13.64%	42.07%	6.11%	47.04%	73.49%	-2.44%	2569.05%	-30.98%	269.75%	279.38%	Upgrade
Retained Earnings	-4,446.21	-3,910.24	-3,206.75	-2,848.13	-2,294	-1,578.93	-1,217.01	-1,166.32	-899.06	-679.03	Upgrade
Comprehensive Income	0.92	-1.66	-0.02	0	0.05	-0.1	-0.38	-0.12	-0.11	-0.1	Upgrade
Shareholders' Equity	859.34	384.95	928.01	761.76	818.19	1,032	789.22	336.69	190.35	247.65	Upgrade
Net Cash / Debt	279.44	372.02	977.48	865.71	395.13	753.36	648.01	312.39	180.57	204.8	Upgrade
Net Cash / Debt Growth	-24.88%	-61.94%	12.91%	119.10%	-47.55%	16.26%	107.44%	73.00%	-11.83%	-22.19%	Upgrade
Net Cash Per Share	3.02	4.25	12.03	11.11	5.37	11.37	11.02	6.41	4.27	5.12	Upgrade
Working Capital	1,926	1,938	2,151	2,069	1,204	1,252	1,140	298.05	162.25	210.93	Upgrade
Book Value Per Share	9.30	4.40	11.42	9.77	11.11	15.58	13.42	6.91	4.50	6.19	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).